Pregnancy morbidity is part of the clinical spectrum of the antiphospholipid syndrome (APS),
a chronic autoimmune condition serologically characterized by the persistent positivity of …

Introduction: Important advancements in pregnancy outcome have been reported in women
with antiphospholipid antibodies (aPL), despite the fact that the treatment of aPL related …

Pregnancy morbidity is one of the clinical manifestations used for classification criteria of
antiphospholipid syndrome (APS). During the 14th International Congress on …

Antiphospholipid syndrome (APS) is a rare systemic autoimmune disease, the obstetric
features of which include recurrent early miscarriage, fetal death at or beyond 10 weeks of …

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by clinical
manifestations such as thrombosis and obstetric complications with documented persistence …

Antiphospholipid syndrome (APS) in pregnancy has a serious impact on maternal and fetal
morbidity. It causes recurrent pregnancy miscarriage and it is associated with other adverse …

Antiphospholipid syndrome (APS) is an acquired thrombophilia with clinical manifestations
associated with the presence of antiphospholipid antibodies (aPL) in patient plasma …

Our objective was to determine whether there is a relationship between low
antiphospholipid (aPL) antibody levels and the obstetrical complications of antiphospholipid …

Anti‐phospholipid syndrome (APS) recapitulates the link between autoimmunity and
pregnancy failure: Acquired anti‐phospholipid antibodies (aPL) play a pathogenic role in …

Background The optimal treatment of women with primary antiphospholipid syndrome (APS)
is still debated. About 20–30% of women with APS remain unable to give birth to healthy …